International Clinical Trial: Efficacy and Safety of Chaigui Granules for Mild-to-Moderate Depression with Liver Stagnation and Spleen Deficiency Syndrome: A Randomized, Double-Blind, Dose-Escalating, Placebo-Controlled Multicenter Phase IIb Trial

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131999) titled 'Efficacy and Safety of Chaigui Granules for Mild-to-Moderate Depression with Liver Stagnation and Spleen Deficiency Syndrome: A Randomized, Double-Blind, Dose-Escalating, Placebo-Controlled Multicenter Phase IIb Trial' on Sept. 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Second Xiangya Hospital of CSU

Condition: Major Depressive Disorder (MDD), also known as depressive disorder, is a category of mood disorders characterized by prominent and persistent depressive symptom clusters induced by various etiologies, accompanied by severe impairment of social functioning.

Interventi...